Krystal Biotech, Inc. Quarterly Depreciation in USD from Q3 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Krystal Biotech, Inc. quarterly/annual Depreciation history and growth rate from Q3 2016 to Q2 2024.
  • Krystal Biotech, Inc. Depreciation for the quarter ending June 30, 2024 was $1.8M, a 50% increase year-over-year.
  • Krystal Biotech, Inc. Depreciation for the twelve months ending June 30, 2024 was $5.94M, a 49.3% increase year-over-year.
  • Krystal Biotech, Inc. annual Depreciation for 2023 was $5.01M, a 89.4% increase from 2022.
  • Krystal Biotech, Inc. annual Depreciation for 2022 was $2.64M, a 42.9% increase from 2021.
  • Krystal Biotech, Inc. annual Depreciation for 2021 was $1.85M, a 23.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.94M $1.8M +$600K +50% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $5.34M $1.43M +$334K +30.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $5.01M $1.51M +$496K +48.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $4.51M $1.2M +$531K +79.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $3.98M $1.2M +$706K +143% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $3.27M $1.09M +$631K +137% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $2.64M $1.02M +$556K +120% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $2.09M $669K +$195K +41.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $1.89M $494K +$19K +4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $1.87M $462K +$24K +5.48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $1.85M $462K +$90K +24.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $1.76M $474K +$75K +18.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $1.68M $475K +$81K +20.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.6M $438K +$103K +30.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $1.5M $372K +$121K +48.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $1.38M $399K +$209K +110% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $1.17M $394K +$219K +125% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $951K $335K +$203K +154% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $748K $251K +$189K +305% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $559K $190K +$152K +400% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $407K $175K +$152K +661% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $255K $132K +$114K +633% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 $141K $62K +$48K +343% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $93K $38K +$33K +660% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 $60K $23K +$20K +667% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $40K $18K +$17K +1700% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $23K $14K Oct 1, 2017 Dec 31, 2017 10-K 2018-03-12
Q3 2017 $5K +$5K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $3K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $1K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q3 2016 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.